Medical Devices Startups

Laza Medical develops AI-powered robotic systems and imaging solutions for structural heart and electrophysiology procedures. The company serves interventional cardiologists and healthcare systems seeking to optimize clinical workflows.

1 investor

4bases develops clinically-validated diagnostic genetic tests, including companion diagnostics and tests for inherited gene mutations, used by healthcare professionals to support therapeutic decisions in precision and preventive medicine. The company operates as an ISO13485-certified, CE-IVD compliant in vitro diagnostics provider.

1 investor

4Blind develops assistive hardware for blind and deafblind people, including the Braille Glove and HaptiBraille Communicator, a tactile pad for schools and universities, and a smart charging adapter. Its devices aim to enable communication and greater independence for deafblind individuals.

1 investor

4D Surgical develops imaging technology for image-guided surgical procedures. The company serves surgical teams and healthcare institutions seeking to improve surgical precision and outcomes.

1 investor

4DMedical develops analytical software that extracts detailed lung function data from standard X-ray and CT scans, enabling non-invasive diagnosis and tailored treatment of respiratory conditions. Its technology serves clinicians and healthcare providers, including VA hospitals treating veterans exposed to toxic substances and airborne hazards.

1 investor

64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics. The company uses massively parallelized screening and computational insights to engineer high-yield cell lines and production technologies that accelerate the manufacturing of next-generation medicines.

1 investor

6Degrees is an Israel-based startup that develops digital accessibility solutions to help people with physical challenges gain independence, improve communication, and increase employability through enhanced digital access.

1 investor

SportOrtho is an orthopedic urgent care practice offering same-day and walk-in appointments for muscle, bone, and joint pain treatment in Middle Tennessee. The practice emphasizes conservative care, physical therapy, and surgical consultation, with 12 locations across the region.

1 investor

73Health provides a SaaS platform for remote health diagnostics powered by AI, enabling healthcare providers to conduct patient examinations and diagnostics from any location. The platform serves clinics, workplaces, and home-based patients globally, with a focus on accessibility and diagnostic accuracy across distributed healthcare settings.

1 investor

7D Surgical develops image-guided surgical navigation systems using machine-vision technology for spine, cranial, and percutaneous procedures. The company's FLASH Navigation Platform and FLASH EVD system assist surgeons in achieving precision during operating room and bedside interventions.

1 investor

99 Technologies develops automated room and targeted surface disinfection systems for healthcare facilities and public environments to prevent healthcare-acquired infections. The company offers integrated disinfection technologies designed for clinical settings and public spaces.

1 investor

A2 Biotherapeutics develops cell therapy technology using the Tmod platform, which applies quantitative drug discovery methods to treat cancer patients.

1 investor

aabo manufactures AI-powered smart rings that track health metrics including heart rate, sleep, stress, and activity 24/7 for consumers seeking preventive health monitoring. The device combines optical sensors with proprietary algorithms to deliver actionable wellness insights without requiring a subscription.

1 investor

Aakha Bio develops multi-specific antibodies for solid tumors that block disease pathways and activate immune cells. The company targets cancer patients with limited treatment options using a platform approach that integrates multiple therapeutic mechanisms into single molecules.

1 investor

ABB Optical Group is the leading distributor of contact lenses, specialty vision products, and related services to eye care professionals across the United States. The company supplies products to nearly two-thirds of U.S. eye care providers and operates its own manufacturing and technology platforms to enhance practice operations and profitability.

1 investor

GOGOTECH develops ABBY, a hybrid manual/power-assist/electric "smart" wheelchair with a smart controller, machine vision (cameras and sensors), and IoT cloud connectivity, priced below $4,000. The company plans to sell directly to consumers as a personal electric vehicle and, pending FDA 510(k) clearance, as a Class II medical device through B2B distributors, targeting both developed and developing markets.

1 investor

Abeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases with high unmet need, including its approved product ZEVASKYN and its lead PSMA-targeted T cell therapy ABO-701 for advanced prostate cancer. It uses ex vivo gene therapy, viral vector, and synthetic immune receptor T cell (SIR-T) technologies to serve patients with genetic diseases and solid tumors.

1 investor

Abionic develops the abioSCOPE, a near-patient rapid diagnostic platform that uses nanofluidic immunoassay technology to deliver lab-quality results from a single drop of blood within minutes. The platform is designed for clinical settings including hospitals and laboratories to enable early detection of conditions such as sepsis.

1 investor

ABYRX develops synthetic, absorbable surgical biomaterials, including a bone hemostat used to stop bleeding on bone surfaces during surgery. Its products are tissue-free and designed to absorb after implantation for use in surgical and orthopedic procedures.

1 investor

Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.

1 investor

Accelerated Biosciences commercializes human trophoblast stem cells (hTSC) and derived platforms for therapeutic development, serving pharmaceutical and biotech partners seeking accelerated pathways to clinical products. The company addresses aging and healthcare cost challenges through cell-based therapeutics.

1 investor

Accelerated Diagnostics is developing decentralised diagnostics for human and veterinary markets, with a product launch planned for July 2026.

1 investor

Accelidea provides decision intelligence software for medical device teams, mapping each product decision to its regulatory, quality, engineering, and submission impact from concept to FDA clearance. It targets MedTech companies developing regulated products, building the evidence, traceability, and documentation needed for FDA submission.

1 investor

Accès Vision operates a network of 44 ophthalmology centers across France offering eye care services such as OCT scans, visual field tests, contact lens fitting, laser capsulotomy and iridotomy. The centers work as Secteur 1 conventioned facilities with third-party payment through Social Security and mutual insurance, serving patients aged 6 and up.

1 investor